Mechanically, circRNA ZNF609 enhances the expression of glucose transporter SLC2A1 by inhibiting miR-378b, thereby promoting glycolysis and cell survival in glioma [115]. The gene discussed is SLC2A1; the disease is central nervous system cancer.